These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35753592)

  • 1. Deep learning based low-activity PET reconstruction of [
    Daveau RS; Law I; Henriksen OM; Hasselbalch SG; Andersen UB; Anderberg L; Højgaard L; Andersen FL; Ladefoged CN
    Neuroimage; 2022 Oct; 259():119412. PubMed ID: 35753592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification and discriminative power of
    Delva A; Van Weehaeghe D; van Aalst J; Ceccarini J; Koole M; Baete K; Nuyts J; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1913-1926. PubMed ID: 31776633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients.
    Sonni I; Fazio P; Schain M; Halldin C; Svenningsson P; Farde L; Varrone A
    J Nucl Med; 2016 Oct; 57(10):1529-1534. PubMed ID: 27230923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Marner L; Korsholm K; Anderberg L; Lonsdale MN; Jensen MR; Brødsgaard E; Denholt CL; Gillings N; Law I; Friberg L
    EJNMMI Res; 2022 Sep; 12(1):56. PubMed ID: 36070114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplified quantification of [
    Brumberg J; Kerstens V; Cselényi Z; Svenningsson P; Sundgren M; Fazio P; Varrone A
    J Cereb Blood Flow Metab; 2021 Jun; 41(6):1291-1300. PubMed ID: 32955955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of dopamine transporters with [(18)F]FE-PE2I: Effects of anti-Parkinsonian drugs.
    Bang JI; Jung IS; Song YS; Park HS; Moon BS; Lee BC; Kim SE
    Nucl Med Biol; 2016 Feb; 43(2):158-64. PubMed ID: 26872440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans.
    Suzuki M; Ito H; Kodaka F; Takano H; Kimura Y; Fujiwara H; Sasaki T; Takahata K; Nogami T; Nagashima T; Nengaki N; Kawamura K; Zhang MR; Varrone A; Halldin C; Okubo Y; Suhara T
    Nucl Med Commun; 2014 Mar; 35(3):231-7. PubMed ID: 24468851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [
    Honhar P; Ebrahimian Sadabad F; Tinaz S; Gallezot JD; Dias M; Naganawa M; Yang Y; Henry S; Hillmer AT; Gao H; Najafzadeh S; Comley R; Nabulsi N; Huang Y; Finnema SJ; Carson RE; Matuskey D
    Brain Commun; 2024; 6(5):fcae345. PubMed ID: 39429243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.
    Sasaki T; Ito H; Kimura Y; Arakawa R; Takano H; Seki C; Kodaka F; Fujie S; Takahata K; Nogami T; Suzuki M; Fujiwara H; Takahashi H; Nakao R; Fukumura T; Varrone A; Halldin C; Nishikawa T; Suhara T
    J Nucl Med; 2012 Jul; 53(7):1065-73. PubMed ID: 22689927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of parametric methods for [¹¹C]PE2I positron emission tomography.
    Jonasson M; Appel L; Engman J; Frick A; Nyholm D; Askmark H; Danfors T; Sörensen J; Furmark T; Lubberink M
    Neuroimage; 2013 Jul; 74():172-8. PubMed ID: 23435214
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Li W; Lao-Kaim NP; Roussakis AA; Martín-Bastida A; Valle-Guzman N; Paul G; Loane C; Widner H; Politis M; Foltynie T; Barker RA; Piccini P
    Mov Disord; 2018 Jan; 33(1):117-127. PubMed ID: 29082547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    Fazio P; Svenningsson P; Forsberg A; Jönsson EG; Amini N; Nakao R; Nag S; Halldin C; Farde L; Varrone A
    J Nucl Med; 2015 May; 56(5):714-20. PubMed ID: 25791993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT for Brain Amyloid: A Feasibility Study for Scan Time Reduction by Deep Learning.
    Lee S; Jung JH; Kim D; Lim HK; Park MA; Kim G; So M; Yoo SK; Ye BS; Choi Y; Yun M
    Clin Nucl Med; 2021 Mar; 46(3):e133-e140. PubMed ID: 33512838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with ¹⁸F-FE-PE2I.
    Ikoma Y; Sasaki T; Kimura Y; Seki C; Okubo Y; Suhara T; Ito H
    Ann Nucl Med; 2015 Oct; 29(8):697-708. PubMed ID: 26134215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Body Biodistribution and Dosimetry of the Dopamine Transporter Radioligand
    Lizana H; Johansson L; Axelsson J; Larsson A; Ögren M; Linder J; Halldin C; Varrone A; Mo SJ
    J Nucl Med; 2018 Aug; 59(8):1275-1280. PubMed ID: 29348315
    [No Abstract]   [Full Text] [Related]  

  • 17. Deep-learning prediction of amyloid deposition from early-phase amyloid positron emission tomography imaging.
    Komori S; Cross DJ; Mills M; Ouchi Y; Nishizawa S; Okada H; Norikane T; Thientunyakit T; Anzai Y; Minoshima S
    Ann Nucl Med; 2022 Oct; 36(10):913-921. PubMed ID: 35913591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter imaging with [
    Jakobson Mo S; Axelsson J; Jonasson L; Larsson A; Ögren MJ; Ögren M; Varrone A; Eriksson L; Bäckström D; Af Bjerkén S; Linder J; Riklund K
    EJNMMI Res; 2018 Nov; 8(1):100. PubMed ID: 30443684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approximating anatomically-guided PET reconstruction in image space using a convolutional neural network.
    Schramm G; Rigie D; Vahle T; Rezaei A; Van Laere K; Shepherd T; Nuyts J; Boada F
    Neuroimage; 2021 Jan; 224():117399. PubMed ID: 32971267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Positron Emission Tomography Imaging of Presynaptic Terminals in Early Parkinson's Disease.
    Delva A; Van Laere K; Vandenberghe W
    Mov Disord; 2022 Sep; 37(9):1883-1892. PubMed ID: 35819412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.